News from biodirection, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 01, 2020, 09:00 ET BioDirection®, Inc. Closes $18 Million Series C Financing Led by Shepherd Kaplan Krochuk, LLC

BioDirection®, Inc. d/b/a NanoDiagnosticsTM, Inc. (NanoDxTM), a privately held medical device company developing cutting-edge and rapid point-of-care ...

Jan 09, 2020, 09:00 ET BioDirection®, Inc. Appoints Dr. Jean-Luc Boulnois to its Board of Directors

BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and...

Nov 04, 2019, 13:24 ET BioDirection, Inc. Announces Manufacturing Facility in Albuquerque, NM

BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and...

Oct 16, 2019, 10:22 ET BioDirection, Inc. Announces Move of Corporate Headquarters to Southborough, Massachusetts

BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and...

Oct 10, 2019, 08:58 ET BioDirection, Inc. and EU Based CENTER-TBI Announce Collaboration in the Field of Diagnosis and Management of Traumatic Brain Injury

BioDirection, Inc., a privately held medical device company developing rapid, whole blood based point-of-care products for the diagnosis and...

Mar 04, 2019, 08:30 ET Sharad H. Joshi Joins BioDirection, Inc. as President and CEO

BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the diagnosis and management ...

Feb 11, 2019, 08:30 ET BioDirection Receives Breakthrough Device Designation from FDA for Tbit™ System

BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and...

Aug 23, 2018, 08:30 ET BioDirection, Inc. Announces Exclusive Worldwide License for Tbit™ System to Diagnose and Monitor Sepsis

BioDirection, Inc., a privately held medical device company developing rapid, whole blood based point-of-care products for the diagnosis and...

Mar 06, 2018, 08:30 ET BioDirection, Inc. Announces Appointment of Dr. Harry E. Rubash as Chairman of Medical Advisory Board

BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of...

Jan 17, 2018, 08:30 ET Retired Brigadier General Jack Hammond Joins the BioDirection Military Advisory Board

BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of...

Jan 10, 2018, 08:30 ET NCAA Collegiate Sports Leader Gene DeFilippo and Head Lacrosse Coach at University of Virginia, Lars Tiffany, Join BioDirection Sports Advisory Board

BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of...

Apr 10, 2017, 08:30 ET BioDirection, Inc. Closes $2 Million Interim Financing

BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the diagnosis and management of...

Apr 03, 2017, 08:30 ET BioDirection Announces Results from Pre-Clinical Study of Tbit™ System for Detection of Traumatic Brain Injury

BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of...

Mar 01, 2017, 07:30 ET BioDirection to Participate in 12th World Congress on Brain Injury

BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection and...

Nov 29, 2016, 08:30 ET BioDirection, Inc. Holds Pre-Submission Meeting with FDA

BioDirection, a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and ...

Feb 03, 2016, 08:30 ET BioDirection, Inc. Closes $4 Million Series B Financing

BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective management of...